SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-18-007255
Filing Date
2018-03-30
Accepted
2018-03-30 16:01:11
Documents
9
Period of Report
2018-05-15
Effectiveness Date
2018-03-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A gern-def14a_20180508.htm DEF 14A 2512610
2 GRAPHIC g2018032916213301231459.jpg GRAPHIC 4615
3 GRAPHIC g2018032916213275931458.jpg GRAPHIC 2149
4 GRAPHIC g2018032916215274031465.jpg GRAPHIC 64470
5 GRAPHIC g2018032916215260631463.jpg GRAPHIC 6653
6 GRAPHIC g2018032916215262831464.jpg GRAPHIC 56676
7 GRAPHIC g2018032916213301431460.jpg GRAPHIC 2149
8 GRAPHIC g2018032916213332331461.jpg GRAPHIC 3517
9 GRAPHIC g2018032916215157731462.jpg GRAPHIC 4054
  Complete submission text file 0001564590-18-007255.txt   2713770
Mailing Address 149 COMMONWEALTH DRIVE SUITE 2070 MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE SUITE 2070 MENLO PARK CA 94025 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

IRS No.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1117
Type: DEF 14A | Act: 34 | File No.: 000-20859 | Film No.: 18726149
SIC: 2834 Pharmaceutical Preparations